SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-131905
Filing Date
2021-10-29
Accepted
2021-10-29 17:26:52
Documents
17
Period of Report
2021-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2131430d1_8k.htm   iXBRL 8-K 33687
2 EXHIBIT 10.1 tm2131430d1_ex10-1.htm EX-10.1 245135
3 EXHIBIT 10.2 tm2131430d1_ex10-2.htm EX-10.2 101753
4 EXHIBIT 10.3 tm2131430d1_ex10-3.htm EX-10.3 54595
5 EXHIBIT 99.1 tm2131430d1_ex99-1.htm EX-99.1 11954
9 GRAPHIC image_001.gif GRAPHIC 2639
  Complete submission text file 0001104659-21-131905.txt   724283

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA armp-20211028.xsd EX-101.SCH 3201
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE armp-20211028_lab.xml EX-101.LAB 34594
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE armp-20211028_pre.xml EX-101.PRE 22721
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2131430d1_8k_htm.xml XML 3505
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 211364424
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences